BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)
FairStock Score: 42/100 — MIXED
| Current Price | $0.94 |
| Market Cap | $— |
| P/E Ratio | — |
| ROE | -179.21% |
| Dividend Yield | —% |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 42/100 — MIXED
| Current Price | $0.94 |
| Market Cap | $— |
| P/E Ratio | — |
| ROE | -179.21% |
| Dividend Yield | —% |
Data from SEC filings. Not investment advice. Scoring methodology